The Cigna Group stock: Higher outlook follows strong Q3 performance

The Cigna Group reported stronger third-quarter operating performance on November 5, raising its minimum 2026 adjusted earnings outlook to 30.60 US dollars per share. The company said the update reflected growth in both Evernorth Health Services and Cigna Healthcare.

According to Nasdaq, total revenue rose 6 percent year over year to 73.7 billion US dollars. Adjusted income from operations was 2.1 billion US dollars, or 7.98 US dollars per share, compared with 7.83 US dollars per share in the year-earlier quarter.

Guidance rises as segments diverge

Reported shareholders' net income fell to 1.4 billion US dollars, or 5.47 US dollars per share, from 1.9 billion US dollars, or 6.98 US dollars, a year earlier. The company attributed the comparison mainly to the absence of an after-tax gain on a business sale in the prior-year period.

The underlying picture was mixed. Cigna Healthcare's adjusted income from operations before tax increased 15 percent to 1.2 billion US dollars, supported by higher investment income and improved operating efficiency. Evernorth Health Services posted adjusted revenue growth of 6 percent, but adjusted operating income before tax declined 4 percent, with lower pharmacy benefit services earnings partly offset by stronger specialty and care services.

The revised full-year outlook is 0.15 US dollars above the previous projection. Management also set segment targets of at least 6.9 billion US dollars for Evernorth and 4.6 billion US dollars for Cigna Healthcare, while narrowing its 2026 medical care ratio outlook to 84.2 percent plus or minus 25 basis points.

Share price and investor focus

The Cigna Group stock traded at 261.95 euros on Lang & Schwarz at 16:29 CET on Monday, November 9, 2026.

US healthcare stocks remain an important market focus for investors tracking medical cost trends and earnings guidance. See current S&P 500 market reports.

See more news and analyses on The Cigna Group stock.